200
Participants
Start Date
November 3, 2025
Primary Completion Date
June 1, 2026
Study Completion Date
September 30, 2026
Observational study
This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Grupo Argentino de Investigación Clínica en Oncología
UNKNOWN
Grupo de Estudios Clínicos Oncológicos Peruano
OTHER
Latin American Cooperative Oncology Group
OTHER